Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2014-09-15, 12:31:02 | version 1.32.01
References 1. Boorn JG van den , Konijnenberg D, Dellemijn TA, et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009;129:2220-32. 2. Kroon MW, Joore IC, Wind BS, et al. Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo. Br J Dermatol 2012;166:532-8. 3. Wind BS, Kroon MW, Beek JF, et al. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study. Br J Dermatol 2010;162:1142-4. 4. Vrijman C, Hosseinpour D, Bakker JG, et al. Provoking factors, including chemicals, in Dutch patients with vitiligo. Br J Dermatol 2013;168:1003-11. 5. Tjin EP, Konijnenberg D, Krebbers G, et al. T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. Clin Cancer Res 2011;17:5736-47. 6. Teulings HE, Tjin EP, Willemsen KJ, et al. Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis. Br J Dermatol 2013;168:733-8. 7. Teulings HE, Overkamp M, Ceylan E, et al. Decreased risk of melanoma and nonmelanoma skin cancer in Patients with vitiligo: a survey among 1307 patients and their partners. Br J Dermatol 2013;168:162-71. 8. Boorn JG van den, Melief CJ, Luiten RM. Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity. Pigment Cell Melanoma Res 2011;24:673-9. 9. Boorn JG van den, Picavet DI, Van Swieten PF, et al. Skin-Depigmenting Agent Monobenzone Induces Potent T-Cell Autoimmunity toward Pigmented Cells by Tyrosinase Haptenation and Melanosome Autophagy. J Invest Dermatol 2011;131:1240-51. 10. Boorn JG van den, Konijnenberg D, Tjin EP, et al. Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One 2010;5:e10626. 41 Kidney with melanoma metastases. BWEADVSMGFINCORR:Opmaak 1 21-07-2014 17:39 Pagina 41